Multi-Drug Resistant Hiv-1 Infection
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Multi-Drug Resistant Hiv-1 Infection trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Multi-Drug Resistant Hiv-1 Infection trials you may qualify forThe goal of this study is to address the gap in published data on viral suppression among people meeting the criteria for virologic failure on dolutegravir (DTG…
The PRESTIGIO Registry is an Observational, prospective, multicentre study that includes patients, regularly followed by Italian Infectious Disease Centres, wit…
In the SHIELD study, the study sponsor seeks to assess safety, PK and antiviral activity for children and adolescents with dual or triple class resistance. It w…
This study is designed to assess the safety and pharmacokinetic profile of 800 mg Trogarzo once every two weeks administered via "IV Push" or intramuscular inje…